Small Fiber Neuropathy and Neuropathic POTS: The Autonomic Connection

Neuropathic POTS — one of the three major POTS subtypes — is caused by small fiber neuropathy (SFN) affecting the autonomic nerves that control blood vessel tone in the lower extremities. Understanding this connection is critical because neuropathic POTS has a different treatment approach than hyperadrenergic or hypovolemic POTS, and misidentifying the subtype leads to suboptimal treatment.

How SFN Causes POTS

In healthy individuals, standing up triggers a reflex vasoconstriction in the lower extremities — the sympathetic nervous system signals blood vessels in the legs and abdomen to constrict, preventing blood from pooling in the lower body. This reflex is mediated by small autonomic C-fibers that innervate the vascular smooth muscle.

In neuropathic POTS, these small autonomic fibers are damaged or reduced in density, impairing the vasoconstriction reflex. When the patient stands, blood pools in the lower extremities (venous pooling), reducing venous return to the heart. The heart compensates by increasing heart rate — producing the tachycardia that defines POTS.

The key distinction from other POTS subtypes is the mechanism:

• Neuropathic POTS: Impaired vasoconstriction due to autonomic SFN → venous pooling → compensatory tachycardia
• Hyperadrenergic POTS: Excessive sympathetic activation → high norepinephrine → tachycardia + high BP
• Hypovolemic POTS: Low blood volume → reduced venous return → compensatory tachycardia

Diagnosing Neuropathic POTS

The diagnosis of neuropathic POTS requires:

1. POTS diagnosis: ≥30 bpm heart rate increase on standing (or ≥40 bpm in patients under 19) within 10 minutes, without orthostatic hypotension

2. Evidence of autonomic SFN: One or more of:

   • Reduced IENFD on skin punch biopsy (distal leg)
   • Abnormal QSART (reduced sweat output in lower extremities)
   • Abnormal thermoregulatory sweat test (TST)
   • Abnormal plasma norepinephrine response (failure to increase appropriately on standing)

3. Exclusion of other subtypes: Normal or low standing norepinephrine (rules out hyperadrenergic); normal blood volume (rules out hypovolemic)

In practice, many patients have overlapping subtypes, and the diagnosis of neuropathic POTS is often made clinically based on the combination of POTS symptoms, neuropathic pain, and autonomic testing abnormalities.

Common Causes of Neuropathic POTS

Treatment Implications

Treatment of neuropathic POTS targets both the autonomic dysfunction and the underlying cause:

Foundational (all neuropathic POTS):

• High sodium and fluid intake to maximize venous return
• Compression garments (waist-high, 20–30 mmHg) to reduce venous pooling
• Recumbent exercise (swimming, rowing, recumbent cycling) to build lower extremity muscle pump

Medications targeting venous pooling:

• Midodrine (alpha-1 agonist) — directly constricts peripheral blood vessels, compensating for the impaired autonomic vasoconstriction
• Fludrocortisone — increases blood volume to compensate for venous pooling
• Pyridostigmine (Mestinon) — enhances ganglionic neurotransmission, potentially improving autonomic nerve function

Treating the underlying cause:

• Sjogren's: hydroxychloroquine, immunosuppression
• MCAS: antihistamines, mast cell stabilizers
• Autoimmune: IVIG, immunomodulation
• Nutritional deficiencies: B12, B6, copper supplementation

What to avoid: Beta-blockers are often less effective in neuropathic POTS than in hyperadrenergic POTS, because the problem is not excessive sympathetic activation but rather impaired vasoconstriction. Some patients with neuropathic POTS actually worsen on beta-blockers.

ChatDys resources: Track your orthostatic symptoms and treatment responses in the Health Tracker. Upload your skin biopsy and QSART results to Biomarkers. Review our POTS Subtypes series to understand how neuropathic POTS compares to other subtypes.